english.prescrire.org > Annual Prescrire Awards > The Prescrire Awards for 2024 > Prescrire Information Awards for 2024 > Prescrire Information Awards for 2024

The Prescrire Awards for 2024

Prescrire Information Awards for 2024

The Prescrire Information Awards for 2024

Prescrire's annual Information Awards are based on the quality of the documentation and information provided by pharmaceutical companies in response to requests by Prescrire's Editorial Staff. We use this documentation when preparing the articles published in the Marketing Authorisations section of our French edition. Prescrire's Information Awards reflect the level of transparency that companies have shown towards Prescrire over the year.

What information does Prescrire request from pharmaceutical companies, and why?
In addition to the information Prescrire gathers through a systematic search of various resources, such as health authorities and the scientific literature, we systematically ask pharmaceutical companies to send us data on their products, from the drug development stage through to post-marketing surveillance. We primarily ask for data on efficacy and adverse effects, packaging items for the products in question, the conditions and restrictions under which patients can access the drugs, their reimbursement status in France, their availability and, where applicable, the reasons for market withdrawal. The purpose of these requests is to provide healthcare professionals with information about drugs that is as up-to-date and comprehensive as possible, in order to promote the correct use of drugs and help ensure patient safety.

7 companies honoured for their transparency

Le Palmarès des Médicaments Prescrire requested information from 91 pharmaceutical companies in 2024. 7 of them earned a place on the 2024 Information Awards Honours List, by responding with detailed documentation. Two of them were rated as “Outstanding” for sending particularly useful information and documents in a timely manner: Ever Pharma and Rhythm Pharmaceuticals.

But the vast majority of companies chose secrecy
15 pharmaceutical companies (of the 91 companies we contacted in 2024) chose not to provide Prescrire with information or documentation. These companies received an Information Red Card. Some of them made it clear that they had no intention of fulfilling our request, by telling us directly or referring us to the health authorities. 69 companies are neither on the Honours List, nor were given a Red Card.

Still too little transparency in 2024
When pharmaceutical companies refuse to share the useful data in their possession with Prescrire – data that cannot be obtained elsewhere – they do a disservice to healthcare professionals and patients. Unfortunately, as in previous years, this was the case with many companies in 2024. Let us honour those who embrace transparency and help to better inform the healthcare professionals who subscribe to Prescrire, for the benefit of patients.
 


Download the full article:
Télécharger
 FREE  "The Prescrire Awards for 2024" Prescrire Int 2025; 34 (270): 136-139. FREE.

 

Back to "The Prescrire Awards for 2024"

©Prescrire May 2025      

Filet

Enjoy full access to Prescrire International, and support independent medical information